Literature DB >> 30664223

New Paradigms for Neural Monitoring in Thyroid Surgery.

Hui Sun1, Che-Wei Wu2, Daqi Zhang1, Özer Makay3, Yishen Zhao4, Paolo Carcofaro5, Hoon Yub Kim6, Gianlorenzo Dionigi7, Antonella Pino8, Ettore Caruso8, Alessandro Pontin8, Vincenzo Pappalardo9.   

Abstract

Intraoperative neuromonitoring (IONM) in thyroid gland surgery provides real-time feedback to the endocrine surgeon regarding the electrophysiological consequences of surgical manipulation of the laryngeal nerves. The goal of monitoring modalities is to detect surgical or physiological insults to the recurrent laryngeal nerve (RLN) while they are still reversible or, in cases where prevention is not an option, to minimize the damage done to these structures during thyroidectomy. In recent decades, monitoring of the RLN has become a fundamental part of endocrine surgery. IONM is a feasible procedure in both open and endoscopic, robotic thyroidectomy. Experts in IONM have organized a working group of general, endocrine, head and neck ENT surgeons and endocrinologists (International Neural Monitoring Study Group; INMSG) to develop standards for practicing this technique in endoscopic and robotic thyroidectomy. This paper presents recent clinical and research experience with intraoperative neural monitoring for thyroid gland surgery.

Mesh:

Year:  2019        PMID: 30664223

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

Review 1.  Neural monitoring in thyroid surgery is here to stay.

Authors:  Daqi Zhang; Antonella Pino; Ettore Caruso; Gianlorenzo Dionigi; Hui Sun
Journal:  Gland Surg       Date:  2020-01

2.  Training Courses in Laryngeal Nerve Monitoring in Thyroid and Parathyroid Surgery- The INMSG Consensus Statement.

Authors:  Che-Wei Wu; Gregory W Randolph; Marcin Barczyński; Rick Schneider; Feng-Yu Chiang; Tzu-Yen Huang; Amanda Silver Karcioglu; Aleksander Konturek; Francesco Frattini; Frank Weber; Cheng-Hsin Liu; Henning Dralle; Gianlorenzo Dionigi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.